AbstractCraniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/parasellar region. CPs have been classified into histopathologically, genetically, clinically and prognostically two distinctive subtypes: adamantinomatous and papillary variants.AimTo determine the immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary CPs.Materials and methodsβ-Catenin, EGFR, ErbB2, and p63 immunostaining was performed on paraffin embedded tissue sections of 25 CPs including 18 adamantinomatous craniopharyngioma (ACP) and 7 cases of papillary craniopharyngiomas (PCPs).Results17 cases (94%) of ACP exhibited strong nuclear/cytoplasmic expression of β-catenin. On the contrary, all cases of PCP...
Abstract Background Recurrence is a common feature of craniopharyngiomas, benign tumors that origin ...
© AANS, 2018. OBJECTIVE Exome sequencing studies have recently demonstrated that papillary craniopha...
PhDCraniopharyngiomas are clinically challenging pituitary tumours that disrupt pituitaryhypothalami...
Craniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/parasellar region. ...
AbstractCraniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/parasellar ...
Introduction: Craniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/paras...
Craniopharyngiomas (CPs) are a heterogeneous group of benign but locally aggressive epithelial tumo...
Craniopharyngiomas are epithelial, sellar tumours with adamantinomatous (aCP) and papillary (pCP) su...
Craniopharyngiomas are rare epithelial tumours arising along the path of the craniopharyngeal duct. ...
Craniopharyngiomas are rare epithelial tumours situated primarily in the sellar/parasellar region, o...
INTRODUCTION: Activating mutations in exon 3 of the β-catenin gene are involved in the pathogen...
Introduction Craniopharyngiomas (CP) are rare epithelial tumors of the sellar region. Two subtype...
Activation of the Wnt/wingless signalling cascade is a key mechanism in developmental morphogenesis,...
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. ...
Craniopharyngiomas (CP) are benign epithelial tumors of the sellar region and can be clinicopatholog...
Abstract Background Recurrence is a common feature of craniopharyngiomas, benign tumors that origin ...
© AANS, 2018. OBJECTIVE Exome sequencing studies have recently demonstrated that papillary craniopha...
PhDCraniopharyngiomas are clinically challenging pituitary tumours that disrupt pituitaryhypothalami...
Craniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/parasellar region. ...
AbstractCraniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/parasellar ...
Introduction: Craniopharyngiomas (CPs) are rare epithelial tumors located mainly in the sellar/paras...
Craniopharyngiomas (CPs) are a heterogeneous group of benign but locally aggressive epithelial tumo...
Craniopharyngiomas are epithelial, sellar tumours with adamantinomatous (aCP) and papillary (pCP) su...
Craniopharyngiomas are rare epithelial tumours arising along the path of the craniopharyngeal duct. ...
Craniopharyngiomas are rare epithelial tumours situated primarily in the sellar/parasellar region, o...
INTRODUCTION: Activating mutations in exon 3 of the β-catenin gene are involved in the pathogen...
Introduction Craniopharyngiomas (CP) are rare epithelial tumors of the sellar region. Two subtype...
Activation of the Wnt/wingless signalling cascade is a key mechanism in developmental morphogenesis,...
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. ...
Craniopharyngiomas (CP) are benign epithelial tumors of the sellar region and can be clinicopatholog...
Abstract Background Recurrence is a common feature of craniopharyngiomas, benign tumors that origin ...
© AANS, 2018. OBJECTIVE Exome sequencing studies have recently demonstrated that papillary craniopha...
PhDCraniopharyngiomas are clinically challenging pituitary tumours that disrupt pituitaryhypothalami...